Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma
Clinical trial NCT03600441 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03600441
- Sponsor
- Xynomic Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-27
- Primary completion
- 2027-12-31
- Enrollment
- 139
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.